Max Robotics — Global Service Robot Directory + US Certification

About

Allan J. Pantuck is a leading urologic oncologist and researcher whose work has significantly advanced the surgical management of genitourinary cancers. His primary research focuses on optimizing surgical techniques for upper tract urothelial carcinoma and improving outcomes through meticulous lymph node dissection. Pantuck’s influential 2017 study on the role of surgical approach in lymph node dissection yield and survival—cited over 60 times—provided critical evidence that more extensive nodal clearance can improve patient prognosis, shaping current surgical standards. He also contributed to comparative effectiveness research in pelvic reconstructive surgery, including the ACCESS trial on abdominal colpopexy strategies. Beyond these landmark papers, Pantuck has been instrumental in developing minimally invasive approaches and refining risk stratification for kidney and bladder cancers. His work, widely recognized for its direct clinical impact, has earned him over 15,000 career citations, placing him among the most cited researchers in urologic oncology. Pantuck’s dedication to evidence-based surgical innovation continues to guide both practicing surgeons and trainees in delivering better, more personalized care.